{"id":984702,"date":"2026-07-24T14:01:22","date_gmt":"2026-07-24T18:01:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/"},"modified":"2026-07-24T14:01:22","modified_gmt":"2026-07-24T18:01:22","slug":"adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/","title":{"rendered":"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN FRANCISCO, July  24, 2026  (GLOBE NEWSWIRE) &#8212; Hagens Berman alerts investors in ADMA Biologics, Inc.\u00a0<strong>(NASDAQ: ADMA)<\/strong> that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company\u2019s financial condition, revenue recognition, inventory distribution, and business practices.<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6L_0QA7_4lag93TgU8NA7oFz_3P5TcBKyoBWprPRg9QsoRs-gqJyy3OrYwv9lAHCIzjkhlmFoXGY5xVGO2VaoYH06y2K4TnZUUvfs4Gj9VB3qs-lHrrT-087KzIUoy-Xo5BObeVTRzyV6dKMWupA92LI9_W0TM1asShoTCFZHEk=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>SUBMIT YOUR ADMA LOSSES TO HAGENS BERMAN NOW<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <strong>Key ADMA Class Action Details<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Class Period: <\/strong>Aug. 9, 2024 \u2013 Mar. 25, 2026<\/li>\n<li>\n          <strong>Lead Plaintiff Deadline: <\/strong>Aug. 10, 2026<\/li>\n<li>\n          <strong>Visit:<\/strong><br \/>\n          <a href=\"http:\/\/www.hbsslaw.com\/investor-fraud\/adma\" rel=\"nofollow\" target=\"_blank\">www.hbsslaw.com\/investor-fraud\/adma<\/a>\n        <\/li>\n<li>\n          <strong>Contact the Firm Now:<\/strong><br \/>\n          <a href=\"mailto:ADMA@hbsslaw.com\" rel=\"nofollow\" target=\"_blank\">ADMA@hbsslaw.com<\/a>\n        <\/li>\n<\/ul>\n<p>\n        <strong>844-916-0895<\/strong>\n      <\/p>\n<p>\n        <strong>Alleged Wrongdoing in ADMA Biologics Lawsuit: <\/strong>\n      <\/p>\n<p>The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">ADMA Biologics engaged in an undisclosed related party transaction;<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">ADMA Biologics used channel stuffing to create an appearance of revenue;<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">ADMA Biologics lacked adequate internal controls; and<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">As a result, Defendants\u2019 statements about ADMA Biologics\u2019 business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/li>\n<\/ul>\n<p>\n        <strong>The Truth Emerges and Market Reaction:<\/strong>\n      <\/p>\n<p>The suit alleges that the misstatements were revealed through several corrective disclosure events, which wiped out substantial shareholder value, exposing investors to severe financial harm.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:25%;width:25%;min-width:25%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Date<\/strong>\n          <\/td>\n<td style=\"max-width:45%;width:45%;min-width:45%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Corrective Event<\/strong>\n          <\/td>\n<td style=\"max-width:30%;width:30%;min-width:30%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Stock Price Impact<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>March 24, 2026<\/strong>\n          <\/td>\n<td style=\"vertical-align: top\">Culper Research publishes short-seller report revealing channel stuffing, rebates, and undisclosed related-party distributor Genesis BioPharma, triggering intense market sell-offs over two trading days as investors digest the revelations.<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>-31.6% combined<\/strong><\/p>\n<p>(March 24: Down 16.6% to $11.33)<\/p>\n<p>(March 25: Down 15.0% to $9.63)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>March 26, 2026<\/strong>\n          <\/td>\n<td style=\"vertical-align: top\">ADMA issues a press release responding to the short-seller report stating it was &#8220;taking appropriate steps to review the assertions,&#8221; alongside a stock rating downgrade from Cantor Fitzgerald, further eroding investor confidence.<\/p>\n<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>-13.9%<\/strong><\/p>\n<p>(Down $1.34 to close at $8.29)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>Hagens Berman\u2019s Investigation <\/strong>\n      <\/p>\n<p>\u201cWe\u2019re investigation whether ADMA made false and misleading statements to investors concealing the reality of its distribution channels and financial reporting, as the suit alleges\u201d said <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vR6TJZGA48WxqbrOb6AXfcwUsX48FXimbzMA6SZssIf7VT_2SgxD--JknNTr18qihxJ_toQqpCiePUdFyf97TJm5Y1zyrbEdfe_MQHJimA-zV3swIXEgHs892523Nm5w\" rel=\"nofollow\" target=\"_blank\"><strong>Reed Kathrein<\/strong><\/a>, the Hagens Berman partner leading the firm\u2019s investigation of the lawsuit\u2019s claims.<\/p>\n<p>\n        <strong>What Affected ADMA Investors Can Do<\/strong>\n      <\/p>\n<p>If you invested in ADMA and have substantial losses, or have knowledge that may assist the firm\u2019s investigation, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=42nhnFCooF8ZhWvvn7OjQ6r6SoioJk3xGsjCD8yff84XfVtBvKY1Suv_RQ-bWKLNwCteArwc2yKxBjV-lAUgbvC7O0_g2VG5XGBCIGbNlUA4QUQvZjeJLDnPfVrLFNOY3yLnLmMY1LjaYeB_vyRT9w==\" rel=\"nofollow\" target=\"_blank\"><strong>submit your information to Hagens Berman<\/strong><\/a> \u00bb<\/p>\n<p>If you\u2019d like more information and answers to frequently asked questions about the ADMA case and the firm\u2019s investigation, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hBpuBf_RyDRk-so63cL7PJF7AkBXSk6WckvBWfL5p70pmCe3y1O-KliCZdf-GsNdQNQteqFBFh4_CgU0O8GHtLFEa6-cmS-JEohJVLxXULtrPSUS8LeutQfudUVu2hdabvv1FK5rH2ix-JDbSy9TVe4WX8exm2HEUppFMBObRtQ=\" rel=\"nofollow\" target=\"_blank\">read more<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4oBtXS62159vf1-1fbIL49bcq9ii2RoegeFzNzvyoSXJRhpWMSuX8mzEpM_sVJep9yjZ8VsLG9Y-J8LP6UeXFc_LRRurTvDqVWwQ5UoOK9P2kqvr5qkx4F0FtCpBSmT_PVl_oLZeLOh6WmKdwoJAmQ==\" rel=\"nofollow\" target=\"_blank\"> \u00bb<\/a><\/p>\n<p>\n        <strong>Whistleblowers: <\/strong>Persons with non-public information regarding ADMA should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at <strong>844-916-0895<\/strong> or email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HaZj2GFY3Qlm_UOUSIkR1m0wFwYCfs_jbEDKWq6X5pDe8ouHaTbRjLB4noIf2ZghE7C2P_Lwfn1-NmUwIJRhuLIQeY4ey2d3jAIT4tC9FbE=\" rel=\"nofollow\" target=\"_blank\">ADMA@hbsslaw.com<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zx60gkaezF1prrik3l36ADJNJfxhNanMWQxFBA-4593k8oLZaaOLLQtB2fCaEhwgzB_30VrwMq5zJlHNeHrbsK45UvDoIbe3CJ9DGPUcMjg=\" rel=\"nofollow\" target=\"_blank\">About Hagens Berman<\/a><br \/>\n        <br \/>Hagens Berman is a global plaintiffs\u2019 rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman\u2019s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yc_aD3U0M_FU1DGT_7kMNqP4YxFRAjZy_OUGZGu7TW2cxNqEebwEzJGhy6AdokZae8FMC4gVzRTFZyISg2K59A==\" rel=\"nofollow\" target=\"_blank\">hbsslaw.com<\/a>. Follow the firm for updates and news at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w2VOMBR1jrojsgvAA_ewtA3gN_QIhM_lH32PK0sgSEDRs1B9euY4MsyedPj4Ef7jwZU6IPnGdQTQtG-LsJKDMV2mgxDZN3BwVG742qNJbI0cikLsZ9f0BMEyjQKff7Ky\" rel=\"nofollow\" target=\"_blank\">@ClassActionLaw<\/a>.\u00a0<\/p>\n<p>Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.<\/p>\n<p>\n        <u>Contact: <\/u><br \/>\n        <br \/>Reed Kathrein, 844-916-0895<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTQzZTIzNDEtNDFjOC00NWIwLTkzODgtNGM3MTE0ZTYyYmQ3LTEwMzAxMDUtMjAyNi0wNy0yNC1lbg==\/tiny\/Hagens-Berman-Sobol-Shapiro-LL.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, July 24, 2026 (GLOBE NEWSWIRE) &#8212; Hagens Berman alerts investors in ADMA Biologics, Inc.\u00a0(NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company\u2019s financial condition, revenue recognition, inventory distribution, and business practices. SUBMIT YOUR ADMA LOSSES TO HAGENS BERMAN NOW Key ADMA Class Action Details Class Period: Aug. 9, 2024 \u2013 Mar. 25, 2026 Lead Plaintiff Deadline: Aug. 10, 2026 Visit: www.hbsslaw.com\/investor-fraud\/adma Contact the Firm Now: ADMA@hbsslaw.com 844-916-0895 Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that: ADMA Biologics engaged in an undisclosed related party transaction; ADMA Biologics used channel stuffing to create an &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-984702","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, July 24, 2026 (GLOBE NEWSWIRE) &#8212; Hagens Berman alerts investors in ADMA Biologics, Inc.\u00a0(NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company\u2019s financial condition, revenue recognition, inventory distribution, and business practices. SUBMIT YOUR ADMA LOSSES TO HAGENS BERMAN NOW Key ADMA Class Action Details Class Period: Aug. 9, 2024 \u2013 Mar. 25, 2026 Lead Plaintiff Deadline: Aug. 10, 2026 Visit: www.hbsslaw.com\/investor-fraud\/adma Contact the Firm Now: ADMA@hbsslaw.com 844-916-0895 Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that: ADMA Biologics engaged in an undisclosed related party transaction; ADMA Biologics used channel stuffing to create an &hellip; Continue reading &quot;ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-24T18:01:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS\",\"datePublished\":\"2026-07-24T18:01:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/\"},\"wordCount\":556,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/\",\"name\":\"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=\",\"datePublished\":\"2026-07-24T18:01:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/","og_locale":"en_US","og_type":"article","og_title":"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS - Market Newsdesk","og_description":"SAN FRANCISCO, July 24, 2026 (GLOBE NEWSWIRE) &#8212; Hagens Berman alerts investors in ADMA Biologics, Inc.\u00a0(NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company\u2019s financial condition, revenue recognition, inventory distribution, and business practices. SUBMIT YOUR ADMA LOSSES TO HAGENS BERMAN NOW Key ADMA Class Action Details Class Period: Aug. 9, 2024 \u2013 Mar. 25, 2026 Lead Plaintiff Deadline: Aug. 10, 2026 Visit: www.hbsslaw.com\/investor-fraud\/adma Contact the Firm Now: ADMA@hbsslaw.com 844-916-0895 Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that: ADMA Biologics engaged in an undisclosed related party transaction; ADMA Biologics used channel stuffing to create an &hellip; Continue reading \"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-24T18:01:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS","datePublished":"2026-07-24T18:01:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/"},"wordCount":556,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/","name":"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=","datePublished":"2026-07-24T18:01:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Nzg2NiM3NzIyNDE3IzIwMTg1MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-investor-alert-adma-biologics-inc-adma-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-hbss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\u2013 HBSS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/984702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=984702"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/984702\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=984702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=984702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=984702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}